ARRY-300 Drug Record

  • ARRY-300 chembl:CHEMBL3545359

    Alternate Names:

    MET-300
    ARRY-300

    Drug Info:

    FDA Approval not approved
    Drug Class Small molecule
    Drug Indications antiinflammatory agent,DMARD,antineoplastic agent
    (0 More Sources)

    Publications:

  • ARRY-300   MAP2K2

    Interaction Score: 0.52

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Novel drug target Novel Target
    Trial Name ARRY-300

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial

  • ARRY-300   MAP2K1

    Interaction Score: 0.41

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Trial Name ARRY-300
    Novel drug target Novel Target

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial

  • ARRY-300   MET

    Interaction Score: 0.2

    Interaction Types & Directionality:
    inhibitor (inhibitory)

    Interaction Info:
    Mechanism of Interaction Hepatocyte growth factor receptor inhibitor
    Direct Interaction yes

    PMIDs:
    None found


    Sources:
    ChemblInteractions

  • TdgClinicalTrial: ARRY-300

    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications antiinflammatory agent,DMARD,antineoplastic agent
    Drug Class Small molecule
    FDA Approval not approved

    Publications:

  • TTD: ARRY-300

    • Version: 2020.06.01

    Alternate Names:
    D05NLD TTD Drug ID

    Drug Info:

    Publications:

  • ChemblDrugs: chembl:CHEMBL3545359

    • Version: ChEMBL_27

    Alternate Names:

    Drug Info:

    Publications:

  • ChemblInteractions: CHEMBL3545359

    • Version: chembl_23

    Alternate Names:

    Drug Info:

    Publications: